Property Summary

NCBI Gene PubMed Count 38
PubMed Score 80.66
PubTator Score 60.78

Knowledge Summary


No data available


  Disease Sources (2)

Disease Target Count P-value
ovarian cancer 8492 2.24554309217199E-7
osteosarcoma 7933 2.48010351718103E-6
medulloblastoma 1524 6.19001483165734E-6
acute quadriplegic myopathy 1157 1.13938885171905E-5
medulloblastoma, large-cell 6234 5.46099902279514E-5
primitive neuroectodermal tumor 3031 6.4046619197784E-5
atypical teratoid / rhabdoid tumor 4369 2.83437492414551E-4
intraductal papillary-mucinous carcinoma (IPMC) 2988 0.00240149122280172
primary Sjogren syndrome 789 0.00442394833752321
sarcoidosis 368 0.00994800455660544
intraductal papillary-mucinous neoplasm (IPMN) 3289 0.0108273835038099
Waldenstrons macroglobulinemia 765 0.0149667000866377
spina bifida 1064 0.0465724185643571
Disease Target Count Z-score Confidence
Cleft palate 125 3.141 1.6
Dyskeratosis congenita 24 3.024 1.5



Accession Q8IU60 C9J778 Q6P2D4 Q7Z5W5 Q8NBG5
Symbols NUDT20


  Ortholog (10)

Species Source
Chimp OMA EggNOG
Macaque OMA EggNOG Inparanoid
Mouse OMA EggNOG Inparanoid
Rat OMA EggNOG Inparanoid
Cow OMA EggNOG Inparanoid
Opossum OMA EggNOG Inparanoid
Platypus OMA EggNOG Inparanoid
Chicken OMA EggNOG
Anole lizard OMA EggNOG Inparanoid
Xenopus OMA EggNOG Inparanoid

Gene RIF (14)

25870104 Human Dcp2 levels and activity are controlled by a competition between decapping complex assembly and Dcp2 degradation.
24510189 The data indicates that DCP2 activation by DCP1 occurs preferentially on the EDC4 scaffold, which may serve to couple DCP2 activation by DCP1 with 5'-to-3' mRNA degradation by XRN1 in human cells.
23926332 The efficiency of incorporation of Mov10, A3G, and A3F into viral particles, which contains both HIV-1 Gag and genomic RNA, is much higher than that of the other P-body proteins AGO2, DCP1a, DCP2, and DDX6
23115303 Data show that Y14 interacts directly with the decapping factor Dcp2 and the 5' cap structure of mRNAs via different but overlapping domains.
23085078 PNRC2 acts in synergy with Dcp1a to stimulate the decapping activity of Dcp2 by bridging the interaction between Dcp1a and Dcp2.
22851315 The efficiency of incorporation of Mov10, A3G, and A3F into viral particles, which contains both HIV-1 Gag and genomic RNA, is much higher than that of the other P-body proteins AGO2, DCP1a, DCP2, and DDX6
21070968 Like Dcp2, Nudt16 also regulates the stability of a subset of mRNAs including a member of the motin family of proteins involved in angiogenesis.
18854154 Knockdown of DCP2 decapping enzyme homolog (S. cerevisiae, DCP2) by siRNA inhibits the early stages of HIV-1 replication in 293T cells infected with VSV-G pseudotyped HIV-1
18361920 These data support the novel notion of the association between Ro52 with hDCP2 protein in cytoplasmic p-bodies, playing a role in mRNA metabolism in response to cellular stimulation.
18039849 hDcp2 can specifically bind to and can regulate the stability of a subset of mRNAs

AA Sequence


Text Mined References (47)

PMID Year Title
26496610 2015 A human interactome in three quantitative dimensions organized by stoichiometries and abundances.
26098573 2015 A conserved mechanism of TOR-dependent RCK-mediated mRNA degradation regulates autophagy.
25870104 2015 Competition between Decapping Complex Formation and Ubiquitin-Mediated Proteasomal Degradation Controls Human Dcp2 Decapping Activity.
25036637 2014 A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways.
24510189 2014 The activation of the decapping enzyme DCP2 by DCP1 occurs on the EDC4 scaffold and involves a conserved loop in DCP1.
24275569 2014 An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
23186163 2013 Toward a comprehensive characterization of a human cancer cell phosphoproteome.
23115303 2013 The RNA-binding protein Y14 inhibits mRNA decapping and modulates processing body formation.
23085078 2012 Structural basis of the PNRC2-mediated link between mrna surveillance and decapping.
22890540 2012 New azaphilones and chlorinated phenolic glycosides from Chaetomium elatum with caspase-3 inhibitory activity.